Patricia Nasshorn

 


Path Nashorn

35+ years of experience in big pharma/biotech/start-ups, and led over 40 completed transactions

With the foundation of her career at J&J, Merck and Bristol-Myers Squibb, Pat Nasshorn held a variety of positions in sales, marketing, BD&L, and general management. She later joined Care Capital, LLC as Executive in Residence, working with many portfolio companies, leading their business development effort, closing over 25 transactions, and co-founding Vanda Pharmaceuticals. Thereafter, Pat continued working as an independent consultant for smaller biotech companies in a broad range of therapeutic areas, including stroke. During that time, among several transactions, she also led the M&A process for Cynapsus, a Canadian biotech that was acquired by Sunovion for $624 million.

 

LinkedIn